Cipla Limited (CIPLA NSE) stock market data APIs
INR1580.3987
-8.02(-0.5%)
as of October 17, 2025
Try our APIs with
free plan!
Cipla Limited Financial Data Overview
Price chart is built with
Anychart
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, such as MI, angina, heart disease, pulmonary disease, kidney failure, Alzheimer's disease, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, central nervous system, HIV/AIDS, respiratory, asthma, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. The company is also involved in the consumer healthcare, biosimilars, and specialty businesses. Cipla Limited was incorporated in 1935 and is based in Mumbai, India.
Prev. Close
1580.3987
Open
1572.3822
High
1568.6888
Low
1547.1094
52 wk Range
1323.5355-1607.8
Market Cap
1 274 331 M
P/E Ratio
23.6415
Shares Outstanding
808 M
Revenue
274 796 M
EPS
16.06
Dividends (Yield)
0
Beta
0.076
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Cipla Limited (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Cipla Limited data using free add-ons & libraries
Get Cipla Limited Fundamental Data
Cipla Limited Fundamental data includes:
- Net Revenue: 274 796 M
- EBITDA: 70 914 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-07-25
- EPS/Forecast: 14.97
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Cipla Limited News
New
Gilead Scores A 'Solid Win' For Its Biggest Moneymaker; Shares Jump
Gilead stock popped Monday after the biotech giant said it signed deals with three generic drugmakers to delay their Biktarvy copycats. Continue Reading View Comments
Gilead stock rises after settling Biktarvy patent disputes
Investing.com -- Gilead Sciences Inc. (NASDAQ:GILD) stock rose 4.5% Monday after the company announced it had settled patent disputes with multiple generic drugmakers over its HIV treatment Biktarvy. ...
India's Gland Pharma posts quarterly profit rise on Cenexi recovery, Europe sales growth
(Reuters) -India's Gland Pharma reported a nearly 50% jump in first-quarter profit on Tuesday, driven by better margins and a recovery at its European unit Cenexi. The company reported a consolidated...
Tariffs should not dictate how Indian drugmakers do business, Cipla CEO says
By Rishika Sadam and Kashish Tandon MUMBAI/BENGALURU (Reuters) - Tariffs should not influence decisions at Indian drug companies, Cipla's top executive said on Friday, as the industry braces for U.S....
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
